UPDATE OVARIAN CANCER TREATMENT

  • by: Lisa Mckinnon
  • recipient: Barbara Sabourin Therapeutic Product Directorate Ottawa, Canada

75% of ovarian cancer patients will not survive beyond five years....sobering stats.  

Women are dying unnecessarily because the government is not investigating new meds nor is it cutting the bureaucratic red tape to get new drugs to market.  Currently, it can take up to 10 years for new drugs to reach a patient!  NOW is the time to implement a "fast track program"  where promising drugs can be offered much sooner.  

It's time to change the standard treatment (carboplatin and paciltaxel) used to treat this disease.  They don't work!   the disease resurfaces.  What is the sense in doing something that doesn't work over and over again?  The government must listen to doctors and patients so policies can be updated, lives can be saved.  

The government must move  quickly to pass bevacizumab and olaparib,  two drugs used to help treat ovarian cancer in the USA, before more lives are lost.

Support more funding for promising research in ovarian cancer.  It is the third most common gynaecological cancer and the most deadly.   The number of patients  inflicted increases every year, but nothing is done about it.  The majority of funds go to support breast cancer, and many new treatments have been discovered,  many lives have been saved.   But NOW it is time for the CDN government to take a closer look at ovarian cancer, and do more to stop this deadly disease. 

By making our voices heard we will remind people of our situation and the importance of coming up with a new ways of dealing with this disease.  

Sign Petition
Sign Petition
You have JavaScript disabled. Without it, our site might not function properly.

Privacy Policy

By signing, you accept Care2's Terms of Service.
You can unsub at any time here.

Having problems signing this? Let us know.